| cycloserine |
| 68-41-7 |
| Seromycin |
| orientomycin |
| Oxamycin |
| Cyclo-D-serine |
| Cicloserina |
| Cyclorin |
| Farmiserina |
| Tisomycin |
| Wasserina |
| Miroseryn |
| Closina |
| D-4-amino-3-isoxazolidinone |
| (4R)-4-amino-1,2-oxazolidin-3-one |
| Cycloserinum |
| Novoserin |
| (+)-4-Amino-3-isoxazolidinone |
| alpha-Cycloserine |
| D-4-amino-3-isoxazolidone |
| (+)-Cycloserine |
| (4R)-4-aminoisoxazolidin-3-one |
| PA 94 |
| PA-94 |
| D-(+)-Cycloserine |
| RO-1-9213 |
| 3-Isoxazolidinone, 4-amino-, (R)- |
| 3-Isoxazolidinone, 4-amino-, d- |
| 3-Isoxazolidinone, 4-amino-, (+)- |
| 95IK5KI84Z |
| DTXSID8022870 |
| CHEBI:40009 |
| NSC-76029 |
| NSC-154851 |
| DTXCID902870 |
| NSC154851 |
| R-4-Amino-3-isoxazolidinone |
| RefChem:56415 |
| J04AB01 |
| (4R)-4-azaniumyl-4,5-dihydro-1,2-oxazol-3-olate |
| 200-688-4 |
| (R)-4-AMINOISOXAZOLIDIN-3-ONE |
| Miroserina |
| Tebemicina |
| Oxamicina |
| 3-Isoxazolidinone, 4-amino-, (4R)- |
| Cycloserin |
| Micoserina |
| E-733-A |
| (R)-4-AMINO-ISOXAZOLIDIN-3-ONE |
| D-Oxamycin |
| MFCD00005353 |
| D-CS |
| D-4-Amino-3-isossazolidone |
| K-300 |
| I-1431 |
| HSDB 3218 |
| D-Oxamicina |
| NSC 154851 |
| (R)-4-Amino-3-isoxazolidone |
| AI3-50153 |
| C3H6N2O2 |
| D-Cycloserine, synthetic |
| D-Cycloserine (Standard) |
| DCS |
| CHEMBL771 |
| SC-49088 |
| CAS-68-41-7 |
| NCGC00016306-01 |
| Oxamicina [Italian] |
| Cicloserina [Italian] |
| M01471 |
| Cycloserinum [INN-Latin] |
| Cicloserina [INN-Spanish] |
| Cycloserine, D- |
| Orientmycin |
| Closerin |
| (R)-(+)-Cycloserine |
| .alpha.-Cycloserine |
| (R)-Cycloserine |
| Seromycin (TN) |
| SMR000058313 |
| D-4-Amino-3-isossazolidone [Italian] |
| R-(+)-Cycloserine |
| (R)-4-Amino-3-isoxazolidinone |
| (4R)-4-Amino-3-isoxazolidinone |
| CYCLOSERINE (D) |
| SR-01000075432 |
| DRG-0195 |
| EINECS 200-688-4 |
| D-amino-3-isoxazolidinone |
| BRN 0080798 |
| UNII-95IK5KI84Z |
| Orientomycin; |
| Cyclomycin; |
| Farmiserina; |
| Micoserina; |
| Seromycin; |
| Cycloserine RS |
| Oxamycin; |
| Oxymycin; |
| Closina; |
| cycloserine-(d) |
| Serine, cyclo- |
| 3-Isoxazolidinone, 4-amino-, D |
| R(+)-4-Amino-3-isoxazolidinone |
| Cycloserine [USP:INN:BAN:JAN] |
| NJ-21 |
| 4AX |
| 3-Isoxazolidinone, 4-amino-, (R) |
| (R)-(+)-4-Amino-3-isoxazolidinone |
| Antibiotic 5915; |
| Antibiotic 8217; |
| Cycloserine, D(+) |
| Antibiotic NJ 21; |
| Antibiotic PA 94; |
| D-Cycloserine, powder |
| Antibiotic K 300; |
| Spectrum_000860 |
| 1pb9 |
| Antibiotic 106-7; |
| Antibiotic 17452; |
| Antibiotic E 733A; |
| Antibiotic I 1431; |
| CYCLOSERINE [MI] |
| Prestwick0_001089 |
| Prestwick1_001089 |
| Prestwick2_001089 |
| Prestwick3_001089 |
| Spectrum2_000084 |
| Spectrum3_000371 |
| Spectrum4_000305 |
| Spectrum5_000797 |
| CYCLOSERINE [INN] |
| CYCLOSERINE [JAN] |
| Lopac-C-1159 |
| Lopac-C-3909 |
| Lopac-C-7005 |
| CYCLOSERINE [HSDB] |
| 3-Isoxazolidinone, 4-amino-, (4R)- (9CI) |
| C 3909 |
| CYCLOSERINE [VANDF] |
| Antibiotic Ro 1-9213; |
| CYCLOSERINE [MART.] |
| Lopac0_000252 |
| SCHEMBL34322 |
| BSPBio_001138 |
| BSPBio_002121 |
| CYCLOSERINE [WHO-DD] |
| CYCLOSERINE [WHO-IP] |
| KBioGR_000890 |
| KBioSS_001340 |
| 4-27-00-05549 (Beilstein Handbook Reference) |
| MLS000758215 |
| MLS001423962 |
| MLS002548887 |
| BIDD:GT0707 |
| D-Cycloserine synth. BP 88 |
| DivK1c_000098 |
| SPECTRUM1500215 |
| SPBio_000008 |
| SPBio_003029 |
| BPBio1_001252 |
| FA6C7F8B-D080-4EA3-978F-1ECFB5A29D09 |
| GTPL9489 |
| orb1308085 |
| Cycloserine (JP18/USP/INN) |
| 4-Amino-3-isoxazolidinone, D- |
| HMS500E20 |
| HY-B0030R |
| KBio1_000098 |
| KBio2_001340 |
| KBio2_003908 |
| KBio2_006476 |
| KBio3_001341 |
| CYCLOSERINE [ORANGE BOOK] |
| NINDS_000098 |
| CYCLOSERINE [USP IMPURITY] |
| HMS1571I20 |
| HMS1920C06 |
| HMS2051C15 |
| HMS2091I14 |
| HMS2098I20 |
| HMS2232F03 |
| HMS3259L19 |
| HMS3260D06 |
| HMS3715I14 |
| Pharmakon1600-01500215 |
| CYCLOSERINE [USP MONOGRAPH] |
| (R)-3-Isoxazolidinone, 4-amino- |
| 4-Amino-3-isoxazolidinone, (R)- |
| CYCLOSERINUM [WHO-IP LATIN] |
| HY-B0030 |
| Tox21_110361 |
| Tox21_500252 |
| BDBM50038178 |
| BDBM50103516 |
| CCG-39705 |
| D-Cycloserine, >=96.0% (NT) |
| EBC-03937 |
| LMPK14000007 |
| NSC756712 |
| s1998 |
| 4-Isoxazolidinamine, 3-oxo-, (D)- |
| AKOS015994626 |
| Tox21_110361_1 |
| AC-4721 |
| D-Cycloserine, Streptomyces orchidaceus |
| DB00260 |
| FC15208 |
| HS-0079 |
| LP00252 |
| NC00050 |
| NC00676 |
| NSC-756712 |
| SDCCGSBI-0050240.P005 |
| IDI1_000098 |
| SMP1_000167 |
| NCGC00015213-01 |
| NCGC00015213-02 |
| NCGC00015213-03 |
| NCGC00016306-02 |
| NCGC00016306-03 |
| NCGC00016306-04 |
| NCGC00016306-05 |
| NCGC00016306-07 |
| NCGC00016306-08 |
| NCGC00016306-17 |
| NCGC00093713-01 |
| NCGC00093713-02 |
| NCGC00260937-01 |
| CAS-339-72-0 |
| ST075697 |
| SY005636 |
| SBI-0050240.P004 |
| AB00443920 |
| CS-0695020 |
| EU-0100252 |
| NS00009120 |
| 3-Isoxazolidinone, 4-amino-, (+)- (8CI) |
| EN300-97131 |
| (4R)-4-amino-2,4,5-trihydroisoxazol-3-one |
| C08057 |
| D00877 |
| AB00443920_09 |
| AB00443920_10 |
| Q418508 |
| SR-01000759389 |
| SR-01000075432-1 |
| SR-01000075432-2 |
| SR-01000075432-5 |
| SR-01000075432-9 |
| SR-01000759389-4 |
| BRD-K87226815-001-17-1 |
| BRD-K87226815-001-18-9 |
| BRD-K87226815-001-19-7 |
| BRD-K87226815-001-20-5 |
| SR-01000075432-10 |
| F2173-1228 |
| Z1198154206 |
| Cycloserine, United States Pharmacopeia (USP) Reference Standard |
| Cycloserine, Pharmaceutical Secondary Standard; Certified Reference Material |
|
There are more than 10 synonyms. If you wish to see them all click here.
|